TITLE

Obstacles to Access: How Pharmacist Refusal Clauses Undermine the Basic Health Care Needs of Rural and Low-Income Women

AUTHOR(S)
Teliska, Holly
PUB. DATE
May 2005
SOURCE
Berkeley Journal of Gender, Law & Justice;2005, Vol. 20, p229
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Examines how pharmacist refusal clauses undermine the basic health care needs of rural and low-income women in the U.S. Methods of contraception used by women in the country; Background on the introduction of pharmacist refusal clauses; Overview of the pharmaceutical standards of care and practice created by the American Pharmaceutical Association; Analysis of pharmacist refusal laws approved in Mississippi and South Dakota and its impact on women living in those states; Recommendations offered to guide state legislators who are considering pharmacist refusal legislation.
ACCESSION #
17686816

 

Related Articles

  • EMERGENCY CONTRACEPTION: A LAST CHANCE TO PREVENT UNINTENDED PREGNANCY. TRUSSELL, JAMES; RAYMOND, ELIZABETH G.; CLELAND, KELLY // Contemporary Readings in Law & Social Justice;2014, Vol. 6 Issue 2, p7 

    Emergency contraception provides women with a last chance to prevent unintended pregnancy after sex. In the United States, available options for emergency contraception are three kinds of pills (levonorgestrel, ulipristal acetate, and regular oral contraceptive pills in different doses) and the...

  • NTI legislation expected in 1998.  // Drug Store News;11/17/97, Vol. 19 Issue 19, pCP4 

    Reports on the Arizona pharmacy board's call for all pharmacists in the state to familiarize themselves with all the issues surrounding narrow therapeutic index (NTI) drugs. Expected introduction of a legislation that limits the right of pharmacists to substitute generics for NTI drugs.

  • Drug patents and promotion: a trade off for Europe? Taylor, David // BMJ: British Medical Journal (International Edition);7/20/91, Vol. 303 Issue 6795, p151 

    Focuses on the impact of the pharmaceutical patent regulation on the pharmaceutical industry in Europe. Desire of the industry for longer patent terms; Provisions of the regulation; Impact of the regulation on industry competition.

  • Egypt.  // MEED: Middle East Economic Digest;2/21/1997, Vol. 41 Issue 8, p27 

    Reports on the Egyptian government's plans to modernize laws governing the pharmaceutical sector. Comments on the country's existing patent laws; Plans to open up the pharmaceutical market.

  • WEEK IN WASHINGTON.  // BioWorld Insight;10/26/2009, Vol. 17 Issue 43, p7 

    The article reports that the U.S. Senate Judiciary Committee passed a bill which prohibits pharmaceutical companies from compensating generic drugmakers to hold the launch of competitive products.

  • Likely inclusion of drugs in MRP net.  // Chemical Business;Aug97, Vol. 11 Issue 1, p49 

    States that the Finance minister of India is studying the question of bringing the pharmaceutical industry under the provision of levying excise on the basis of the maximum retail prices. Details of the provision.

  • The House-Passed Prescription Drug Bill Still Faces Strong Obstacles in the Senate. Hess, Glenn // Chemical Market Reporter;07/03/2000, Vol. 258 Issue 1, p1 

    Discusses the status of the House-passed prescription drug bill in the United States. Supporters of the bill; Plan of United States President Bill Clinton to veto the bill; Reaction of drug manufacturers on the issue.

  • PhRMA Takes Stand Against Affordable Prescription Bill.  // Chemical Market Reporter;10/04/99, Vol. 256 Issue 14, p9 

    Looks at the implication of the Affordable Prescription Drugs Act of 1999 in the United States on the brandname drug industry. Comments from Alan Holmer, president of the Pharmaceutical Research and Manufacturers of America.

  • Active Pharmaceutical Ingredient Watch.  // Chemical Market Reporter;8/4/2003, Vol. 264 Issue 3, p8 

    Reports developments on approved drugs manufactured by pharmaceutical industry as of August 4, 2003 in the U.S.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics